Title | Date | Type | Flag |
|---|---|---|---|
| AFT reports ongoing sales growth and R&D progress | 07/07/2026, 08:30 NZST 07/07/2026, 08:30 NZST7/7, 08:30 | GENERAL | — |
| Notice of Annual Meeting of Shareholders 2026 | 02/07/2026, 16:57 NZST 02/07/2026, 16:57 NZST2/7, 16:57 | MEETING | — |
| FDA allows AFT’s injectable iron project clinical study | 24/06/2026, 08:30 NZST 24/06/2026, 08:30 NZST24/6, 08:30 | GENERAL | — |
| Capital Change Notice | 22/06/2026, 08:30 NZST 22/06/2026, 08:30 NZST22/6, 08:30 | SECISSUE | — |
| Annual Meeting and Closing Date for Director Nominations | 25/05/2026, 08:54 NZST 25/05/2026, 08:54 NZST25/5, 08:54 | MEETING | — |
| issue of unlisted Options | 22/05/2026, 08:30 NZST 22/05/2026, 08:30 NZST22/5, 08:30 | SECISSUE | — |
| FY26 dividend distribution notice | 21/05/2026, 08:59 NZST 21/05/2026, 08:59 NZST21/5, 08:59 | CORPACT | Material or Prescribed announcementsP |
| AFT delivers double digit revenue growth and record earning | 21/05/2026, 08:49 NZST 21/05/2026, 08:49 NZST21/5, 08:49 | FLLYR | Material or Prescribed announcementsP |
| AFT Pharmaceuticals names Stuart Houliston CFO | 18/05/2026, 09:00 NZST 18/05/2026, 09:00 NZST18/5, 09:00 | ADMIN | — |
| AFT to announce full year results on May 21 2026v | 08/05/2026, 16:35 NZST 08/05/2026, 16:35 NZST8/5, 16:35 | GENERAL | — |
| March Quarter FY 2026 Investor Update | 07/04/2026, 08:55 NZST 07/04/2026, 08:55 NZST7/4, 08:55 | GENERAL | — |
| Chief Financial Officer update | 24/03/2026, 12:03 NZDT 24/03/2026, 12:03 NZDT24/3, 12:03 | GENERAL | — |
| Court of Appeal dismisses PBL Port Wine Stain profit claim | 09/03/2026, 09:27 NZDT 09/03/2026, 09:27 NZDT9/3, 09:27 | GENERAL | — |
| December Quarter FY 2026 Investor Update | 15/01/2026, 08:30 NZDT 15/01/2026, 08:30 NZDT15/1, 08:30 | GENERAL | — |